Boston, MA 09/03/2014 (wallstreetpr) – According to a report made public by The Shareholders Foundation, Inc., a shareholder of InterMune Inc (NASDAQ:ITMN) filed a lawsuit in order to stop the proposed acquisition of ITMN by Roche. Both the companies agreed on a price of $74 per share. All the investors who had bought the shares of ITMN on or before 24 August could exercise some of their rights. They are advised to get in touch with Shareholders Foundation, Inc for more information on this matter.
Why 24 August is stated as an important date:
August 24, 2014 is very important in terms of this transaction as InterMune Inc (NASDAQ:ITMN) and Roche both entered into a merger agreement on this day. According to the agreement, Roche will acquire ITMN completely on the price of $74 per share. It will be an all-cash transaction.
Although experts claim that it may not be the best value for ITMN stock, hence the company should think once again. According to plaintiff, the price offered by Roche is not fair as it doesn’t reflect the intrinsic value of the stock of ITMN. In the case this transaction is executed, all the shareholders of ITMN will not get the growth rate on their investment that they deserve. Those who bought the shares of InterMune Inc (NASDAQ:ITMN) before 24 August, still have a few options that they can use to stop this transaction; hence, plaintiff has urged to use these rights. For any information, they can get in touch with Shareholders Foundation that will tell them their rights and how they can use those rights to stop this proposed acquisition.
The Shareholders Foundation Inc. is a formal settlement claim filing and portfolio legal monitoring service. It conducts in-depth research related to a lot of shareholder issues and then conducts the analysis with the help of market experts to suggest best options to shareholders. It helps them in claim actions, judgments, settlements and any other legal service.
